These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9139559)

  • 1. Intravenous immune globulin therapy for neurologic diseases.
    Dalakas MC
    Ann Intern Med; 1997 May; 126(9):721-30. PubMed ID: 9139559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases.
    Dalakas MC
    Neurology; 1998 Dec; 51(6 Suppl 5):S2-8. PubMed ID: 9851723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravenous gamma globulins in neuroimmunologic diseases.
    Latov N; Chaudhry V; Koski CL; Lisak RP; Apatoff BR; Hahn AF; Howard JF
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S126-32. PubMed ID: 11586280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.
    Tavee J; Brannagan TH; Lenihan MW; Muppidi S; Kellermeyer L; D Donofrio P;
    Muscle Nerve; 2023 Oct; 68(4):356-374. PubMed ID: 37432872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
    Elovaara I; Hietaharju A
    Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.
    Lünemann JD; Nimmerjahn F; Dalakas MC
    Nat Rev Neurol; 2015 Feb; 11(2):80-9. PubMed ID: 25561275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.
    Dalakas MC
    Muscle Nerve; 1999 Nov; 22(11):1479-97. PubMed ID: 10514226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in the treatment of neurologic disorders.
    Živković S
    Acta Neurol Scand; 2016 Feb; 133(2):84-96. PubMed ID: 25997034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with intravenous immunoglobulins: complications and side-effects.
    Wittstock M; Benecke R; Zettl UK
    Eur Neurol; 2003; 50(3):172-5. PubMed ID: 14530624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
    Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V;
    Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
    Stangel M; Hartung HP; Marx P; Gold R
    J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
    Lewańska M; Selmaj K
    Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.